July 2006

|
Volume 18 Issue 7
Percutaneous treatment of coronary chronic total occlusions (CTOs) remains one of the major challenges in interventional cardiology. Recent data have shown that successful percutaneous recanalization of coronary CTOs results in improved survival as w…
Treatment of chronic total occlusions (CTO) produces more difficulties, angst and trepidation than any other lesion subset in interventional cardiology. Many of the difficulties stem from: difficulty engaging the occlusion, chronicity of the occlusio…
Clopidogrel bisulfate is a thienopyridine oral antiplatelet agent that acts via irreversible inhibition of adenosine diphosphate-mediated platelet activation and aggregation.1 It is widely used in the treatment and secondary prevention of a variety o…
A 66-year-old male presented with exertional dyspnea and palpitations. The electrocardiogram showed atrial fibrillation and episodes of atrial flutter. Subsequent echocardiography revealed signs of right-sided heart failure with dilatation of the rig…
To the Editor: Percutaneous coronary interventions of thrombotic or friable lesions, such as in acute myocardial infarctions, can often result in distal embolization. To circumvent this problem, modern techniques frequently involve pretreatment with…
Dear Readers, This issue of the Journal of Invasive Cardiology includes several interesting articles selected for their importance to the care of cardiac patients. The first research article, submitted by Dr. Ilias Mylonas and collea…
Various coronary artery anomalies have been described in the literature. We report an unusual case of anomalous coronary artery circulation that has not been described in the literature. Case Report. A 67-year-old female was admitted to our institut…
Case Report. The patient was a 61-year-old Caucasian male with a past medical history of hypertension and coronary artery disease (with a history of stent placement to the circumflex artery 5 years ago). He was admitted to an outside hospital with ac…
Since its introduction by Ross et al1 and Cope2 in 1959, transseptal catheterization has gained widespread acceptance among cardiologists as an important tool in the interventional laboratory. Although originally embraced mainly by interventional car…
Thrombolysis remains the most commonly used reperfusion therapy in acute myocardial infarction (AMI) in the United Kingdom, Europe and the developing world. Recent evidence suggests that thrombolysis may be equivalent to primary percutaneous coronary…